Cargando…
MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
BACKGROUND: Addiction is a personal and social problem worldwide, and has physical and psychological effects on consumers’ health. Recently, miRNAs have been described as noninvasive biomarkers. Currently, methamphetamine abuse (MA) is mainly diagnosed by chromatography. This study aimed to investig...
Autores principales: | Rezai Moradali, Saman, Soltanzadeh, Hossein, Montazam, Hassan, Asadi, Zahra, Fathi, Shima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences and Health Services
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743824/ https://www.ncbi.nlm.nih.gov/pubmed/36544981 http://dx.doi.org/10.34172/ahj.2022.1298 |
Ejemplares similares
-
Silencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuse
por: Bai, Ying, et al.
Publicado: (2016) -
Evaluation of microRNA let-7b-3p expression levels in methamphetamine abuse
por: Demirel, Göksun, et al.
Publicado: (2023) -
Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2016) -
Molecular mechanisms of the microRNA-132 during tumor progressions
por: Moghbeli, Meysam, et al.
Publicado: (2021) -
Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson’s disease patients
por: Shu, Yu, et al.
Publicado: (2020)